GGrantIndex
← Search

CPVOD-19 DEVELOPMENT OF DF-COV FOR THE TREATMENT AND PREVENTION OF COVID-19 AND ASSOCIATED IMMUNOPATHOLOGIC RESPIRATORY COMPLICATIONS

$6,881,254FY2021Defense Health AgencyDOD

Dana-Farber Cancer Institute, Inc.

Investigators

View source on USAspending →